Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Clinical Trial ID NCT00783172

PubWeight™ 0.85‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00783172

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int J Oncol 1999 0.96
2 Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma. Cancer Chemother Pharmacol 2005 0.93
3 Treatment of advanced pancreatic cancer with opioid growth factor: phase I. Anticancer Drugs 2004 0.90
4 Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice. Cancer Lett 1997 0.90
5 Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer. Open Access J Clin Trials 2010 0.85
Next 100